You have spent years watching your FTP, tracking your power-to-weight, comparing Strava KOMs. Fair enough. Those numbers measure performance in the present tense. But there is another number sitting on your dashboard — or available through a ramp test, or estimable from your Garmin — that predicts something far more consequential than your next race result. It predicts how many years you have left. Not just alive, but functional. Riding. Moving well. Independent.
That number is VO2max. And the research connecting it to longevity is not speculative. It is among the most robust findings in exercise science, built on cohort studies following hundreds of thousands of people over decades.
This piece walks through what the published evidence says about cycling and lifespan. Not the wellness-influencer version. The data. How much riding actually extends your life, where the returns diminish, what happens to your heart after decades of endurance training, why your knees are probably fine, and what the practical training shift looks like when the goal moves from winning crits to riding strong at 75.
VO2max: The Number That Predicts Decades
In 2018, Dr Mandsager and colleagues at the Cleveland Clinic published a study in JAMA Network Open that tracked 122,007 patients through treadmill stress testing and followed them for a median of eight years. The finding that landed was stark: patients in the lowest quintile of cardiorespiratory fitness had a mortality risk roughly five times higher than those in the top quintile. That association was stronger than the mortality risk from smoking. Stronger than diabetes. Stronger than coronary artery disease.
Read that again. Being unfit was a better predictor of dying than being a smoker.
The dose-response was continuous. Each step up in fitness category — from low to below-average, from below-average to above-average, from above-average to high, from high to elite — carried a further reduction in mortality risk. There was no ceiling where more fitness stopped helping. Even the jump from "high" to "elite" fitness — corresponding roughly to the difference between a recreationally active person and a competitive endurance athlete — produced a statistically significant mortality benefit.
For cyclists, this matters because VO2max is the physiological measure underpinning that fitness ranking, and VO2max is highly trainable. Peter Attia — who has done more than anyone to bring the longevity-fitness connection into public conversation — frames VO2max as the single most powerful lever you can pull. Not because other things don't matter, but because the effect size dwarfs nearly every other modifiable risk factor. If you had to pick one biomarker to improve for the sake of living longer and living better, VO2max is the one.
The age dimension makes this more relevant, not less. VO2max declines with age in everyone. Sedentary adults lose roughly 10% per decade. Trained endurance athletes lose less — estimates range from 5% to 7% per decade in those who maintain structured training. The gap between those trajectories, compounded over 30 or 40 years, is the difference between a 70-year-old who is functionally independent and one who is not. The threshold for independent living — being able to climb stairs, carry shopping, get off the floor — corresponds to a VO2max of roughly 18 ml/kg/min. If you are sitting at 45 ml/kg/min at age 50 and losing 10% per decade because you stopped training, the maths puts you below that threshold in your late seventies. If you are losing 5% per decade because you kept riding, you arrive at the same age with reserves to spare.
The practical implication is that maintaining — or improving — your VO2max through your forties, fifties, and sixties is not just about cycling performance. It is about buying functional years.
The Dose-Response Curve: How Much Riding Is Enough?
The Copenhagen City Heart Study is one of the largest and longest-running datasets on cycling and mortality. It followed approximately 45,000 participants in Copenhagen for over 25 years, with cycling as a specifically measured variable. The headline result: regular cyclists had a 30% lower all-cause mortality rate than non-cyclists. Men who cycled regularly gained an average of 2.9 years of life expectancy. Women gained 2.0 years.
The dose-response data was the more interesting part. The mortality benefit increased with cycling volume up to a point, then flattened. That plateau landed at roughly 3.5 to 4 hours per week of moderate-intensity cycling. Beyond that, additional hours added diminishing returns. The curve did not reverse — more cycling was not harmful — but the incremental benefit per additional hour became progressively smaller.
The Norwegian HUNT study, which followed over 44,000 participants for 15 years, confirmed this shape. The largest mortality reduction came from moving out of the sedentary category entirely. Going from no exercise to meeting the WHO guideline of 150 minutes per week of moderate activity cut all-cause mortality risk by roughly 30-40%. Doubling that — 300 minutes per week — added further benefit, but the marginal reduction was smaller. Tripling or quadrupling it added a bit more, but the curve was clearly flattening.
For the masters cyclist doing 8 to 12 hours per week, this raises an obvious question: am I getting longevity benefit from those extra hours, or am I just getting performance benefit?
The answer is both, but the longevity curve has mostly flattened by the time you pass 5-6 hours per week. The additional volume serves racing, gran fondo targets, the social ride calendar. Those are legitimate goals. But if the sole purpose of riding is healthspan, 4-5 hours per week of well-structured cycling — with appropriate intensity distribution — captures the vast majority of the mortality benefit. The 15-hour weeks that many enthusiasts ride are performance-driven, not health-driven. Nothing wrong with that, as long as you know which goal you are serving.
The consistency finding matters more than the volume finding. Every major longitudinal study shows that the mortality benefit accrues through sustained participation over years and decades. A single year of heavy training followed by five years on the sofa does not bank fitness. The body does not work like a savings account. It works like a subscription: you get the benefit while you keep paying.
The Athlete's Heart: When Should You Worry?
Long-term endurance training changes the structure of the heart. The chambers enlarge. The walls thicken slightly. Resting heart rate drops — 40-50 bpm is common in trained cyclists, and some sit in the mid-30s. Collectively, these adaptations are called the athlete's heart, and they have been well documented since the 1890s.
For the overwhelming majority of endurance athletes, the athlete's heart is a benign adaptation. The larger chambers pump more blood per beat (higher stroke volume), which is the mechanical basis for a high VO2max. The lower resting heart rate reflects improved parasympathetic tone. These are not signs of damage. They are signs of a heart that has adapted to sustained aerobic demand.
The concern that circulates in cycling forums — and occasionally in headlines — is about arrhythmias. Specifically atrial fibrillation (AF). Several studies, including a 2017 meta-analysis by Morseth and colleagues, found that lifelong endurance athletes had a higher prevalence of AF than age-matched sedentary controls. The relative risk increase was roughly 1.3 to 1.8 times, depending on the study.
That sounds alarming until you look at the absolute numbers. The baseline prevalence of AF in the general population over 60 is roughly 3-5%. A relative risk of 1.5 puts endurance athletes at perhaps 5-7%. The absolute increase is small. And critically, the all-cause mortality in the endurance athlete group was still substantially lower than in the sedentary group, even accounting for the higher AF prevalence. The heart rhythm risk did not erase the cardiovascular benefit. It was not even close to erasing it.
The current consensus — reflected in the 2020 ESC guidelines on sports cardiology — is that the athlete's heart is benign in the absence of underlying structural or genetic abnormalities. The small subset of endurance athletes who develop problematic arrhythmias typically have pre-existing substrates: family history, subtle cardiomyopathies, or conduction pathway abnormalities that were present before they ever clipped in. Training volume may accelerate the expression of an existing vulnerability, but it does not create the vulnerability from nothing.
The practical takeaway for the masters cyclist: if you have a family history of sudden cardiac death, cardiomyopathy, or arrhythmia, get screened. An ECG and echocardiogram with a sports cardiologist who understands the athlete's heart is money well spent. If you have no symptoms and no family history, the structural changes in your heart are almost certainly doing exactly what they are supposed to do — making you a more efficient endurance machine.
Joint Preservation: Why Cycling Ages Better Than Running
The persistent anxiety about joint wear from exercise is mostly misplaced, but it does have a grain of truth — and cycling sits on the favourable side of that grain.
Running generates ground-reaction forces of 2-3 times bodyweight with every stride. Over a 10km run, that is tens of thousands of impact cycles. The cartilage in the knee and hip joints absorbs, distributes, and recovers from those forces, and for most runners, it does so without degradation. The 2017 meta-analysis by Alentorn-Geli and colleagues found that recreational runners had lower rates of knee and hip osteoarthritis than sedentary people — running, at moderate volumes, appears to be protective rather than destructive.
But the picture shifts at higher volumes and over longer timeframes, particularly for people who already have early cartilage changes. Elite runners and ultra-distance runners showed higher OA rates than recreational runners. And for anyone with existing joint pathology — meniscal tears, chondral defects, prior ACL reconstruction — the repetitive impact of running can accelerate progression.
Cycling eliminates that variable. The pedal stroke is a closed-chain movement with no ground-reaction impact. The knee moves through a controlled range of motion under load, but without the shock of foot-strike. The cartilage is loaded — which is actually necessary for its nutrition, since articular cartilage is avascular and depends on cyclic loading to drive fluid exchange — but it is loaded smoothly rather than impulsively.
For the masters athlete with early osteoarthritis, this distinction is not theoretical. It is often the reason they end up on a bike in the first place. Clinicians routinely recommend cycling as the one form of cardiovascular exercise that maintains fitness without aggravating arthritic joints. The anecdotal evidence is everywhere in the cycling community: former runners whose knees drove them off the roads and onto two wheels, where they found they could train hard without pain.
The one caveat is bone density. Running, because of its impact loading, stimulates bone remodelling. Cycling does not. Several studies have shown that competitive cyclists have lower bone mineral density than runners or mixed-sport athletes, and in some cases, lower than sedentary controls. This is a real concern, particularly for female cyclists and for anyone with osteoporosis risk factors. The mitigation is resistance training — which provides the mechanical loading stimulus that cycling lacks — and, where tolerable, some running or walking in the training mix. Your joints may have pushed you off the road, but your bones still need impact.
Muscle Mass: The Longevity Factor Cycling Misses
Sarcopenia — the progressive loss of skeletal muscle mass and function with age — begins in the fourth decade and accelerates after 60. The average sedentary adult loses 3-8% of muscle mass per decade after 30. By 70, the cumulative loss is enough to compromise functional independence. Falls, fractures, metabolic decline, insulin resistance — sarcopenia is the quiet engine behind most of what makes old age debilitating.
Cycling is excellent cardiovascular training. It is poor sarcopenia prevention. The pedal stroke recruits a limited range of muscles through a limited range of motion. The hip extensors and knee extensors do the primary work. The upper body, the posterior chain, the trunk stabilisers — all of these get minimal stimulus from riding. Even the leg muscles involved in pedalling are trained in a repetitive, concentric-dominant pattern that does not produce the kind of hypertrophic or strength stimulus that counteracts muscle loss.
This is not an argument against cycling. It is an argument for addition. The masters cyclist who rides five days a week and does no resistance training is building a spectacular aerobic engine on a slowly eroding structural foundation. The aerobic gains are real. The structural erosion is also real. And at some point — usually in the late sixties or seventies — the structural deficit catches up.
The intervention is well established. Two resistance training sessions per week, targeting the major muscle groups through full range of motion, is sufficient to halt and often reverse age-related muscle loss. The evidence base includes the landmark Fiatarone study from 1994, which showed that even frail nursing home residents in their eighties and nineties could gain significant muscle mass and strength with progressive resistance training. If it works at 90, it works at 55.
For the cyclist, this does not mean becoming a gym rat. It means adding two focused sessions per week built around exercises that cycling does not provide: single-leg work like lunges and step-ups, hip hinge patterns like hip thrusts and glute bridges, upper-body pushing and pulling, and trunk stability work. The sessions do not need to be long — 30 to 40 minutes of well-chosen exercises at appropriate intensity gets the job done.
The protein requirement sits alongside the resistance work. Joe Friel's recommendation of 1.6-2g per kg bodyweight per day is consistent with the broader sports nutrition consensus for masters athletes. Anabolic resistance — the reduced muscle protein synthesis response to a given protein dose that comes with age — means older athletes need more protein than younger ones to achieve the same effect. For a 75kg cyclist, that is 120-150g per day, spread across meals, with a particular emphasis on the post-training and pre-sleep doses.
Shifting the Dashboard: Training for Decades, Not Just Seasons
The performance-oriented cyclist measures progress in FTP, 5-minute power, 20-minute power, race results. Those metrics track competitive fitness. They do not directly track healthspan.
The longevity-oriented cyclist needs a different dashboard. VO2max is the headline metric — tracked through periodic ramp tests, or estimated from smart watches, or inferred from field data. The trend matters more than any single number. A 55-year-old with a VO2max of 42 ml/kg/min who is holding that number steady year on year is in a profoundly different position from one whose VO2max has been declining by 3 ml/kg/min per year.
The training emphasis shifts accordingly. Zone 2 volume — the long, conversational-pace riding that improves mitochondrial density, fat oxidation, and cardiac efficiency — becomes the foundation rather than the filler. Iñigo San Millán, whose zone 2 research at the University of Colorado has influenced everyone from Peter Attia to UAE Team Emirates, frames it as the single most important training zone for metabolic health. Not for race performance. For the underlying metabolic machinery that determines how well your body functions across decades.
But zone 2 alone is not enough. The VO2max data is clear: maintaining your ceiling requires regularly touching it. That means VO2max intervals — 3 to 5 minute efforts at 90-100% of maximum heart rate — remain in the programme even when the goal is health rather than competition. The frequency can be lower than for a racing cyclist. Once per week is sufficient to maintain VO2max in a masters athlete who is no longer chasing peak performance. The sessions can be shorter. But they cannot be absent.
The intensity distribution that emerges for the longevity-focused masters cyclist looks like a softer version of the polarised model that Prof. Stephen Seiler has spent decades studying. Perhaps 80-85% of training time in zone 2, 10-15% at VO2max intensity, and 5% or less in the threshold zone. The threshold work — the sweetspot and tempo efforts that dominate many training plans — produces performance but also produces the most fatigue per unit of benefit. For the rider whose primary goal is functional decades, reducing threshold volume and reallocating it to zone 2 or to recovery is a reasonable trade.
Recovery itself becomes a more deliberate practice. The 45-year-old who could absorb three hard sessions in a week at 35 may need 72 hours between VO2max efforts at 55. This is not decline. It is physiology. The adaptation response is intact; the timeline is extended. Respecting that timeline with planned recovery days and deloads is what keeps the training sustainable across years.
What This Looks Like in Practice
A weekly structure for the masters cyclist prioritising longevity over race performance might look like this:
Monday — Resistance training, 35-40 minutes. Single-leg press or leg press, lunges, hip thrusts or glute bridges, cable rows, push-ups or dumbbell press, planks and side planks. Two to three sets of 8-12 reps per exercise. Progressive overload — add weight when the top of the rep range is comfortable.
Tuesday — Zone 2 ride, 60-90 minutes. Conversational pace. Heart rate below 75% of max. Nose-breathing is a useful intensity cue — if you cannot sustain it, you are too high.
Wednesday — Off or easy spin, 30 minutes. True recovery.
Thursday — VO2max intervals. 15-minute warm-up, then 4-5 x 3 minutes at 90-95% of max HR with 3-minute recovery between efforts. 10-minute cool-down. Total session roughly 60 minutes.
Friday — Resistance training, 35-40 minutes. Same structure as Monday, same or adjacent exercises. Variation week to week is fine but not necessary — consistency of stimulus matters more than exercise novelty.
Saturday — Long zone 2 ride, 2-3 hours. The group ride fits here, provided you can keep it in the correct intensity range. If the Saturday group ride turns into a race, that is your VO2max session and Thursday becomes zone 2.
Sunday — Off or easy walk. Full rest if fatigue has accumulated.
Total cycling: roughly 5-6 hours. Total resistance training: roughly 70-80 minutes. That is enough to maintain VO2max, build and preserve muscle mass, protect joint and bone health, and capture the vast majority of the longevity benefit the research identifies.
The exercises listed above deliberately avoid heavy spinal-loaded movements. For the 35-55 demographic, the injury risk from heavy barbell work does not justify the marginal benefit when safer alternatives exist. Leg press rather than back squats. Hip thrusts and glute bridges rather than heavy barbell pulls. Cable rows rather than bent-over barbell rows. The stimulus reaches the same muscles with a substantially lower risk profile. You are training for decades. Getting injured in the gym defeats the purpose.
The Long Game
The research converges on a message that should be encouraging for anyone who loves riding a bike. Cycling is one of the most effective forms of exercise for extending both lifespan and healthspan. The dose required for the health benefit is moderate — less than most enthusiasts already ride. The cardiovascular adaptations are overwhelmingly positive. The joint profile is favourable. The one gap — muscle preservation — is fillable with two resistance sessions per week.
The shift in mindset is the harder part. Moving from a framework where training success means a higher FTP to one where training success means a stable or improving VO2max, maintained muscle mass, and healthy joints requires letting go of some of the metrics that cycling culture prizes. It does not mean riding less or riding easier. It means riding with a different intent, measuring different things, and accepting that the decades ahead are worth at least as much planning as the next race season.
You are already doing the most important thing. You ride. Consistently, probably more than you think is necessary for health, and with more intensity than most of the population will ever touch. The additions — resistance work, protein, VO2max monitoring, a bit more zone 2 and a bit less threshold — are refinements, not overhauls.
The best time to start thinking about longevity was ten years ago. The second best time is after you finish reading this.
If you want to dig into this kind of thing with other riders who are thinking past the next season — training for decades, not just results — the Roadman community on Skool is where those conversations happen.